Cancer Pharm Flashcards
Inhibits dihydrofolate reductase;
Folate analog;
Toxicity causes GI and bone marrow problems
Methotrexate
Reversal of Methotrexate toxicity
Leucovorin
Alkylating agent (nitrosiurease); inter and intrastrand covalent links with DNA; lipophilic and able to cross BBB to tx glioblastoma
Carmustine
Antimitotic agent (M phase);
Binds B tubulin;
Prevents microtubule polymerization
Vinca Alkyloids: Vinblastine, Vincristine
Antimitotic agent (M phase);
Binds B tubulin;
Promotes microtubule polymerization;
Prevents microtubule depolymerization
Taxanes: Paclitaxel
Antimitotic agent (M phase);
Binds B tubulin;
Promotes microtubule polymerization;
Prevents microtubule depolymerization
***avoids resistance due to p-glycoprotien
Cabazitaxel
Antitumor Abx;
Produces free radicals that can damage the heart
Doxorubicin
Antitumor Abx;
Produces free radicals that can damage the lungs
Bleomycin
Peptide that mimics VEGFR;
Binds VEGF, inhibiting angiogenesis
Ziv-alfibercept
Monoclonal Ab that binds VEGF, inhibiting angiogenesis
Bevacizumab
Inhibits tyrosine kinase domain of BCR-ABL fusion protein;
Tx for CML w/ t(9:22)
Imatinib
Purine analog that inhibits purine synthesis;
Metabolized to active form by HGPRT;
May also be metabolized by xanthine oxidase
6-Mercaptopurine
Dose of oral 6-MP must be reduced in pts also taking _______ due to the drug increasing the bioavailability of 6-MP
Allopurinol
(inhibited xanthine oxidase increases bioavailibility of 6-MP as more is shunted to HGPRT to transform into active cytotoxic agent)
Drugs susceptible to p-glycoprotein resistance (increased MDR1 expression)
Natural products (from bacteria or plants)
- Anthrocyclines (doxyrubicin)
- Vinca Alkyloids
- Etoposide
- Paclitaxel
- Dactinomycin
Doxyrubicin MOA
topoisomerase II inhibitor (inhibit DNA replication)